ALLIX Fundamental Analysis - WALLIX GROUP

Fundamental Rating

Taking everything into account, ALLIX scores 2 out of 10 in our fundamental rating. ALLIX was compared to 113 industry peers in the Software industry. ALLIX has a bad profitability rating. Also its financial health evaluation is rather negative. ALLIX is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALLIX has reported negative net income.

In the past year ALLIX had a positive cash flow from operations.

In the past 5 years ALLIX always reported negative net income.

In multiple years ALLIX reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -3.53%, ALLIX is not doing good in the industry: 67.26% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -24.56%, ALLIX is doing worse than 76.99% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-3.53%
ROE	-24.56%
ROIC	N/A

ROA(3y)-11.47%

ROA(5y)-10.77%

ROE(3y)-44.92%

ROE(5y)-35.34%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALLIX has a Gross Margin of 108.52%. This is amongst the best in the industry. ALLIX outperforms 98.23% of its industry peers.

In the last couple of years the Gross Margin of ALLIX has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for ALLIX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	108.52%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.14%

GM growth 5Y-0.06%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.

The debt/assets ratio for ALLIX has been reduced compared to a year ago.

2.2 Solvency

ALLIX has an Altman-Z score of 1.22. This is a bad value and indicates that ALLIX is not financially healthy and even has some risk of bankruptcy.

ALLIX has a Altman-Z score of 1.22. This is in the lower half of the industry: ALLIX underperforms 69.03% of its industry peers.

A Debt/Equity ratio of 1.07 is on the high side and indicates that ALLIX has dependencies on debt financing.

ALLIX has a worse Debt to Equity ratio (1.07) than 83.19% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	N/A
Altman-Z	1.22

ROIC/WACCN/A

WACC8.46%

2.3 Liquidity

A Current Ratio of 0.79 indicates that ALLIX may have some problems paying its short term obligations.

ALLIX has a worse Current ratio (0.79) than 83.19% of its industry peers.

A Quick Ratio of 0.79 indicates that ALLIX may have some problems paying its short term obligations.

The Quick ratio of ALLIX (0.79) is worse than 82.30% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.79
Quick Ratio	0.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALLIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.11%, which is quite impressive.

ALLIX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.72%.

ALLIX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.85% yearly.

EPS 1Y (TTM)79.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%45.98%

Revenue 1Y (TTM)17.72%

Revenue growth 3Y13.73%

Revenue growth 5Y15.85%

Sales Q2Q%18.89%

3.2 Future

The Earnings Per Share is expected to grow by 62.60% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 22.11% on average over the next years. This is a very strong growth

EPS Next Y103.9%

EPS Next 2Y74.7%

EPS Next 3Y62.6%

EPS Next 5YN/A

Revenue Next Year21.15%

Revenue Next 2Y21.78%

Revenue Next 3Y22.11%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALLIX. In the last year negative earnings were reported.

With a Price/Forward Earnings ratio of 27.27, ALLIX can be considered very expensive at the moment.

ALLIX's Price/Forward Earnings is on the same level as the industry average.

The average S&P500 Price/Forward Earnings ratio is at 23.78. ALLIX is around the same levels.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.27

4.2 Price Multiples

ALLIX's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	48.38

4.3 Compensation for Growth

ALLIX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 62.60% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y74.7%

EPS Next 3Y62.6%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALLIX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

WALLIX GROUP

EPA:ALLIX (12/12/2025, 7:00:00 PM)

22.75

+0.05 (+0.22%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)11-03 2025-11-03

Earnings (Next)03-18 2026-03-18/amc

Inst Owners10.83%

Inst Owner ChangeN/A

Ins Owners19.72%

Ins Owner ChangeN/A

Market Cap153.34M

Revenue(TTM)36.95M

Net Income(TTM)-1.80M

Analysts84

Price Target31.11 (36.75%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)35.56%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-50%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.61%

Revenue NY rev (3m)-0.6%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.27
P/S	4.15
P/FCF	N/A
P/OCF	37.13
P/B	19.17
P/tB	N/A
EV/EBITDA	48.38

EPS(TTM)-0.28

EYN/A

EPS(NY)0.83

Fwd EY3.67%

FCF(TTM)-0.42

FCFYN/A

OCF(TTM)0.61

OCFY2.69%

SpS5.48

BVpS1.19

TBVpS-1.82

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.53%
ROE	-24.56%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	108.52%
FCFM	N/A

ROA(3y)-11.47%

ROA(5y)-10.77%

ROE(3y)-44.92%

ROE(5y)-35.34%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.14%

GM growth 5Y-0.06%

F-Score5

Asset Turnover0.72

Health

		Industry Rank	Sector Rank
Debt/Equity	1.07
Debt/FCF	N/A
Debt/EBITDA	2.35
Cap/Depr	121.43%
Cap/Sales	18.86%
Interest Coverage	N/A
Cash Conversion	124.02%
Profit Quality	N/A
Current Ratio	0.79
Quick Ratio	0.79
Altman-Z	1.22

F-Score5

WACC8.46%

ROIC/WACCN/A

Cap/Depr(3y)134.6%

Cap/Depr(5y)153.57%

Cap/Sales(3y)19.1%

Cap/Sales(5y)22.25%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)79.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%45.98%

EPS Next Y103.9%

EPS Next 2Y74.7%

EPS Next 3Y62.6%

EPS Next 5YN/A

Revenue 1Y (TTM)17.72%

Revenue growth 3Y13.73%

Revenue growth 5Y15.85%

Sales Q2Q%18.89%

Revenue Next Year21.15%

Revenue Next 2Y21.78%

Revenue Next 3Y22.11%

Revenue Next 5YN/A

EBIT growth 1Y75.02%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year144.36%

EBIT Next 3Y66.73%

EBIT Next 5YN/A

FCF growth 1Y50.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y548.91%

OCF growth 3Y-37.14%

OCF growth 5YN/A

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALLIX.PA.

Can you provide the valuation status for WALLIX GROUP?

ChartMill assigns a valuation rating of 3 / 10 to WALLIX GROUP (ALLIX.PA). This can be considered as Overvalued.

What is the profitability of ALLIX stock?

WALLIX GROUP (ALLIX.PA) has a profitability rating of 2 / 10.

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

Can you provide the valuation status for WALLIX GROUP?

What is the profitability of ALLIX stock?